We developed a proprietary drug discovery engine called TTP Translational Technology® that we used to discover and develop novel therapeutics for major diseases. Almost all of the drug candidates in our pipeline were discovered using TTP Translational Technology®.
TTP Translational Technology® is a highly automated and fully integrated drug discovery process, which translates genomic and proteomic data into promising small molecule therapeutics in a high throughput fashion, bypassing many of the traditional bottlenecks in drug discovery.
We have used this technology to discover and develop drugs for our own pipeline and also for pharmaceutical partners under research collaboration agreements. The technology has delivered clinical drug candidates against a wide range of biological targets including protein-protein interactions, receptor modulators, and enzyme inhibitors.